4.7 Article

New developments in osteoarthritis pharmacological therapies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

The effects of platelet-rich plasma injection in knee and hip osteoarthritis: a meta-analysis of randomized controlled trials

Yujie Dong et al.

Summary: This meta-analysis included 24 RCTs, with PRP injections showing significant improvements in various scores for knee and hip OA patients compared to other injections. The positive effects of PRP were more pronounced in knee OA than in hip OA, especially in the short-term follow-up.

CLINICAL RHEUMATOLOGY (2021)

Article Orthopedics

Effect and usability of anti-inflammatory drug plasters for knee osteoarthritis: A crossover, double-blind, repeated measures, randomized controlled trial

Hideki Tanabe et al.

Summary: This study aimed to examine the effects of anti-inflammatory drug plasters for knee osteoarthritis and patients' clinical preference for using plasters. The results showed that both first- and second-generation plasters were superior to the base only in terms of clinical functions, but there was no significant difference between the two generations.

JOURNAL OF ORTHOPAEDIC SCIENCE (2021)

Article Rheumatology

Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial

Pascal Richette et al.

Summary: The study found that tocilizumab was not more effective than placebo in relieving pain in patients with hand osteoarthritis. Apart from the primary endpoint, there were no significant differences in secondary outcomes between the tocilizumab group and the placebo group.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Rheumatology

Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

Claudia Kedor et al.

Summary: OA-TREAT is the first large randomized PBO controlled trial focusing on EOA, and the results showed that HCQ was no more effective than PBO for changes in pain, function, and radiographic scores in the 52-week period. The overall safety findings were consistent with the known profile of HCQ.

RMD OPEN (2021)

Article Orthopedics

Intra-articular Injections of the Hip and Knee With Triamcinolone vs Ketorolac: A Randomized Controlled Trial

Kevin Jurgensmeier et al.

Summary: This study compared the effectiveness of ketorolac and triamcinolone in treating symptoms of primary osteoarthritis of the hip and knee, finding no significant differences in patient-reported outcome measures between the two treatments. Triamcinolone showed slightly greater durability in knee injections. Overall, both interventions had minimal adverse effects.

JOURNAL OF ARTHROPLASTY (2021)

Article Rheumatology

The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial

Hans Guehring et al.

Summary: The study assessed pain outcomes and cartilage thickness change in knee osteoarthritis patients at risk of further progression treated with sprifermin. The subgroup at risk showed faster disease progression and maintained net benefit on total cartilage thickness during treatment.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)

Article Rheumatology

Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial

Marc C. Hochberg et al.

Summary: In patients with stable NSAID therapy, subcutaneous tanezumab resulted in more joint safety events than continued NSAIDs, with differences dependent on dosage. Tanezumab 5 mg significantly improved pain and physical function at 16 weeks compared to NSAIDs.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Medicine, General & Internal

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis A Randomized Controlled Trial

Philip G. Conaghan et al.

ANNALS OF INTERNAL MEDICINE (2020)

Review Rheumatology

A roadmap to target interleukin-6 in osteoarthritis

Renske Wiegertjes et al.

RHEUMATOLOGY (2020)

Article Orthopedics

OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis

R. R. Bannuru et al.

OSTEOARTHRITIS AND CARTILAGE (2019)

Editorial Material Orthopedics

A tale of two TrkA inhibitor trials: same target, divergent results

D. A. Walsh et al.

OSTEOARTHRITIS AND CARTILAGE (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Intra-articular Coricosteroid Injections in the Nip and Knee: Perhaps Not as Safe as We Thought?

Andrew J. Kompel et al.

RADIOLOGY (2019)

Review Rheumatology

Osteoarthritis: the genesis of pain

Kai Fu et al.

RHEUMATOLOGY (2018)

Article Medicine, General & Internal

Hydroxychloroquine Effectiveness in Reducing Symptoms of Hand Osteoarthritis A Randomized Trial

Sarah R. Kingsbury et al.

ANNALS OF INTERNAL MEDICINE (2018)

Article Medicine, Research & Experimental

Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711

Erik Lindstrom et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2018)

Review Rheumatology

What is new in pain modification in osteoarthritis?

Rachel E. Miller et al.

RHEUMATOLOGY (2018)

Review Rheumatology

Calcium crystal deposition diseases - beyond gout

Geraldine M. McCarthy et al.

NATURE REVIEWS RHEUMATOLOGY (2018)

Article Medicine, General & Internal

Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis A Randomized Clinical Trial

Timothy E. McAlindon et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medicine, General & Internal

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

P. M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Rheumatology

Wnt/β-catenin Signaling in Osteoarthritis and in Other Forms of Arthritis

Yachuan Zhou et al.

CURRENT RHEUMATOLOGY REPORTS (2017)

Article Medicine, General & Internal

Osteoarthritis

Johanne Martel-Pelletier et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Article Rheumatology

Intraarticular Sprifermin (Recombinant Human Fibroblast Growth Factor 18) in Knee Osteoarthritis

L. Stefan Lohmander et al.

ARTHRITIS & RHEUMATOLOGY (2014)

Review Rheumatology

Towards a mechanism-based approach to pain management in osteoarthritis

Anne-Marie Malfait et al.

NATURE REVIEWS RHEUMATOLOGY (2013)

Review Anesthesiology

Antagonism of Nerve Growth Factor-TrkA Signaling and the Relief of Pain

Patrick W. Mantyh et al.

ANESTHESIOLOGY (2011)

Review Biotechnology & Applied Microbiology

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept

Arpad Szallasi et al.

NATURE REVIEWS DRUG DISCOVERY (2007)

Review Medicine, General & Internal

Systematic review of topical capsaicin for the treatment of chronic pain

L Mason et al.

BMJ-BRITISH MEDICAL JOURNAL (2004)